SCHEMBL8286374

SCHEMBL8286374

CCOC(=O)c1cc(C(F)(F)F)c2c(=O)cc(Nc3cccc(F)c3)n(-c3cccc(F)c3)c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.45
BCHE P06276 3/20 0.43
ACHE P22303 3/20 0.43
HTT P42858 2/20 0.42
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
MGAM O43451 1/20 0.39
GAA P10253 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
MAPT P10636 3/20 0.39
POLB P06746 1/20 0.38
CACNA1B Q00975 1/20 0.38
APBA1 Q02410 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
THRB P10828 1/20 0.37
PTGES O14684 1/20 0.36
MDM2 Q00987 1/20 0.36
SYK P43405 1/20 0.36
ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286378 0.86 PDE11A (0.49) PDE11AMAPTMDM2
SCHEMBL8287868 0.79 PDE11A (0.47) PDE11AMAPTMDM2
SCHEMBL8361753 0.79 PDE11A (0.46) PDE11AMAPTMDM2SYK
SCHEMBL8286089 0.78 PDE11A (0.45) PDE11AHTTMAPTPOLBMDM2
SCHEMBL8287147 0.78 HTT (0.44) BCHEACHEHTTMAPK1SMN1; SMN2
SCHEMBL8286372 0.77 CSF1R (0.47) PDE11AHTTSMN1; SMN2GAAMAPT
SCHEMBL8286392 0.76 PDE11A (0.62) PDE11AHTTSMN1; SMN2GAAMAPT
SCHEMBL8285196 0.75 PDE11A (0.64) PDE11AHTTSMN1; SMN2GAAMAPT
SCHEMBL8286385 0.75 PDE11A (0.79) PDE11AMAPK1
SCHEMBL8286388 0.74 PDE11A (0.58) PDE11AGAAMDM2SYKALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed